Tele-trials offer an innovative way to enhance, improve and extend clinical trials and potentially overcome disparities, enable access to new treatments and improve patient outcomes.
In this webinar, our esteemed panelists will discuss:
– How tele-trials have transformed clinical trials and the rapid advances made due to COVID-19
– Ways tele-trials can improve access to healthcare for rural, remote and regional communities, and vulnerable groups such as Culturally and Linguistically Diverse (CaLD) and Aboriginal and Torres Strait Islander populations
– What education or other supports are necessary to assist the clinical trials sector to more broadly embrace tele-trials and other digital health technologies
– Anticipated benefits of tele-trials including workforce development opportunities and cost advantages
– Potential barriers, best practice guidelines, patient perspectives, international adoption and future directions.
This webinar is proudly brought to you by DHCRC, Curtin University and La Trobe University.
– Dr Megan Robertson, Chair, Scientific Advisory Council, Biomedical Research Victoria (panel chair)
– Dr Kate Burbury, Deputy Chief Medical Officer, Peter MacCallum Cancer Centre
– Professor Ian Olver AM, Professorial Research Fellow, School of Psychology, University of Adelaide
– Melanie Gentgall, CEO, PRAXIS Australia
Dr Megan Robertson, Chair, Scientific Advisory Council, Biomedical Research Victoria
Megan Robertson is an alumna of the University of Melbourne where she completed a Bachelor of Medicine, Bachelor of Surgery (MBBS). She is the current Group Chief Research Officer for St Vincent’s Health Australia and the Director of Research at St Vincent’s Hospital, Melbourne. She also works as a Senior Intensivist at Epworth HealthCare (Richmond and Freemasons). She is a Board member of the Digital Health CRC, St Vincent’s Institute of Medical Research and FearLess (PTSD-ANZ), the Council at Queen’s College University of Melbourne, and the Tuckwell Scholarship Selection Panel at ANU. She also works with national bodies including the Australian Commission on Safety and Quality in Healthcare, AusBiotech, and the National Health and Medical Research Council. Previously, she held positions as the Director of Professional Affairs, CICM, as the Executive Director of Research at Epworth HealthCare, and as the Co-Director of the Intensive Care Unit at Epworth Freemasons.
Dr Kate Burbury, Deputy Chief Medical Officer, Peter MacCallum Cancer Centre
Associate Professor Kate Burbury is consultant haematologist; stream lead for myeloproliferative disorders (MPD)/chronic myeloid leukaemia (CML) and lead clinician for haemostasis, thrombosis and peri-operative optimisation, including pre-habilitation, for all major cancer surgery patients at the VCCC. Kate is a member of professional societies, scientific committees, council member for Haematology Society for Australia and New Zealand, and actively involved in the development of expert guidelines and governance structures for both the institution and external working parties, including European Leukaemia Network: flow cytometry in myelodysplastic syndromes (MDS). Kate is committed to clinical and translational research, and the provision of the best care to patients through their treatment journey.
Professor Ian Olver AM, Professorial Research Fellow, School of Psychology, University of Adelaide
Ian Olver AM MD PhD is a medical oncologist, cancer researcher and bioethicist. He is currently Professorial Research Fellow, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide. His previous roles have included being CEO, Cancer Council Australia and Clinical Director, Royal Adelaide Hospital Cancer Centre. His research interests embrace supportive care in cancer and psycho-oncology.
Melanie Gentgall, CEO, PRAXIS Australia
Melanie is a Registered Nurse by profession, whose extensive experience includes working in the NT, providing dialysis and renal transplant care to local Aboriginal and Torres Strait Islander communities, and supporting research undertaken by groups such as Menzies. The last 20 years of her career have been spent largely within the Australian Clinical Trials environment across various roles, including the establishment of a Phase 1 Clinical Trials Unit for the University of Adelaide. She is a passionate and dedicated research advocate who is committed to improving access to education and training of the highest quality for the entire Australian research sector. This is made possible through her current role as founding CEO of PRAXIS Australia, an NFP and registered charity, recognised as a leader in the Australian HREC, research and clinical trials education sector. Melanie has been an active member of several Australian HRECS since 2009.